Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2021) Vol. 42, Iss. 36, pp. 3599-3726
Open Access | Times Cited: 8496

Showing 1-25 of 8496 citing articles:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4163
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, et al.
European Heart Journal (2022) Vol. 43, Iss. 38, pp. 3618-3731
Open Access | Times Cited: 2025
2023 ESC Guidelines for the management of acute coronary syndromes
Robert A. Byrne, Xavier Rosselló, J J Coughlan, et al.
European Heart Journal (2023) Vol. 44, Iss. 38, pp. 3720-3826
Open Access | Times Cited: 1731
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Katja Zeppenfeld, Jacob Tfelt‐Hansen, Marta Riva, et al.
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 3997-4126
Closed Access | Times Cited: 1621
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal (2022) Vol. 43, Iss. 41, pp. 4229-4361
Open Access | Times Cited: 1481
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1435
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Michael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg, et al.
European Heart Journal (2021) Vol. 42, Iss. 35, pp. 3427-3520
Open Access | Times Cited: 1325
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2200879-2200879
Open Access | Times Cited: 1139
2023 ESC Guidelines for the management of cardiomyopathies
Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3503-3626
Open Access | Times Cited: 937
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3627-3639
Open Access | Times Cited: 899
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
Sigrun Halvorsen, Julinda Mehilli, Salvatore Cassese, et al.
European Heart Journal (2022) Vol. 43, Iss. 39, pp. 3826-3924
Open Access | Times Cited: 613
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 611
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Muthiah Vaduganathan, Kieran F. Docherty, Brian Claggett, et al.
The Lancet (2022) Vol. 400, Iss. 10354, pp. 757-767
Open Access | Times Cited: 604
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
John B.A.G. Haanen, Michel Obéid, Lavinia Spain, et al.
Annals of Oncology (2022) Vol. 33, Iss. 12, pp. 1217-1238
Open Access | Times Cited: 562
Extracorporeal Life Support in Infarct-Related Cardiogenic Shock
Hölger Thiele, Uwe Zeymer, İbrahim Akın, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 14, pp. 1286-1297
Closed Access | Times Cited: 373
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload
Wilfried Müllens, Jeroen Dauw, Pieter Martens, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 13, pp. 1185-1195
Open Access | Times Cited: 358
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas, et al.
European Heart Journal (2024) Vol. 45, Iss. 36, pp. 3415-3537
Open Access | Times Cited: 348
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Kunihiro Matsushita, Shoshana H. Ballew, Angela Yee‐Moon Wang, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 696-707
Closed Access | Times Cited: 307
Left bundle branch area pacing outcomes: the multicentre European MELOS study
Marek Jastrzębski, Grzegorz Kiełbasa, Óscar Cano, et al.
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 4161-4173
Open Access | Times Cited: 293
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
Stefan Frantz, Moritz Hundertmark, Jeanette Schulz‐Menger, et al.
European Heart Journal (2022) Vol. 43, Iss. 27, pp. 2549-2561
Open Access | Times Cited: 288
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Isabelle C. Van Gelder, Michiel Rienstra, Karina V Bunting, et al.
European Heart Journal (2024)
Open Access | Times Cited: 284
Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial
Petr Ošťádal, Richard Rokyta, Jiří Karásek, et al.
Circulation (2022) Vol. 147, Iss. 6, pp. 454-464
Open Access | Times Cited: 279
Heart Failure With Preserved Ejection Fraction
Margaret M. Redfield, Barry A. Borlaug
JAMA (2023) Vol. 329, Iss. 10, pp. 827-827
Closed Access | Times Cited: 278
Cardiogenic Shock After Acute Myocardial Infarction
Marc D. Samsky, David A. Morrow, Alastair Proudfoot, et al.
JAMA (2021) Vol. 326, Iss. 18, pp. 1840-1840
Open Access | Times Cited: 239
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
Paul R. Kalra, John G.F. Cleland, Mark C. Petrie, et al.
The Lancet (2022) Vol. 400, Iss. 10369, pp. 2199-2209
Open Access | Times Cited: 239
Page 1 - Next Page

Scroll to top